# Commission Regulation (EC) No 426/98 of 23 February 1998 amending Annexes I, II and III of Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin (Text with EEA relevance), Annex

Extent: E+W+S+N.I.

A.. Annex I is modified as follows:
2.. Antiparasitic agents
2.1. Agents acting against endoparasites
2.1.3. Benzimidazoles and pro-benzimidazoles
Pharmacologically active substance
Marker residue
Animal Species
MRLs
Target tissues
Other provisions
‘Triclabendazole
Sum of the extractable residues that may be oxidised to ketotriclabendazole
Bovine, ovine
100 μg/kg
Muscle, liver, kidney
Not for use in animals producing milk for human consumption’
B.. Annex II is modified as follows:
2.. Organic compounds
Pharmacologically active substance(s)
Animal species
Other provisions
‘Isoflurane
Equidae
For use as anaesthetic only’
C.. Annex III is modified as follows:
2.. Antiparasitic agents
2.1. Agents acting against ectoparasites
2.1.2. Acyl urea derivates
Pharmacologically active substance(s)
Marker residue
Animal Species
MRLs
Target tissues
Other provisions
‘Teflubenzuron
Teflubenzuron
Salmonidae
500 μg/kg
Muscle and skin in natural proportions
Provisional MRLs expire on 1.7.1999’

---
Source: https://www.legislation.gov.uk/eur/1998/426/annex (the official version)
Page: https://openlegislation.uk/eu-regulation-1998-426/annex
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.